EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review

GlobalData
49 Pages - GLDATA61473
$125.00

EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

EnWave Corp (EnWave) is an industrial technology company that develops commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. Its technology finds application in food and pharmaceutical industry. The company licenses use of REV equipment to partner companies for specific products and geographic markets. NutraDried LLP, a subsidiary of EnWave develops and distributes REV dried snack products, namely Moon Cheese, for the North American market. EnWave currently has three commercial REV platforms, namely, nutraREV for food industry applications; quantaREV for food industry applications; and powderREV for pharmaceutical applications. The company is also developing freezeREV a multi-vial prototype technology for pharmaceutical applications. EnWave is headquartered in Vancouver, Canada.

EnWave Corp Key Recent Developments

Aug 26, 2016: EnWave Announces 2016 Third Quarter Consolidated Interim Financial Results
Aug 12, 2016: EnWave Receives $480,000 of Previously Restricted Cash Collateral
Jul 28, 2016: EnWave Hires Experienced Senior Vice President to Lead Global Pharmaceutical Business Development Strategy
May 26, 2016: EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016
Feb 26, 2016: EnWave Reports Consolidated Interim Financial Results for the First Quarter Fiscal Year 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
EnWave Corp - Key Facts 6
EnWave Corp - Key Employees 7
EnWave Corp - Key Employee Biographies 8
EnWave Corp - Major Products and Services 9
EnWave Corp - History 10
EnWave Corp - Company Statement 16
EnWave Corp - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 – Company Analysis 19
EnWave Corp - Business Description 19
EnWave Corp - Corporate Strategy 20
EnWave Corp - SWOT Analysis 21
SWOT Analysis - Overview 21
EnWave Corp - Strengths 21
EnWave Corp - Weaknesses 22
EnWave Corp - Opportunities 23
EnWave Corp - Threats 24
EnWave Corp - Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios - Capital Market Ratios 26
Financial Ratios - Annual Ratios 27
Performance Chart 29
Financial Performance 29
Financial Ratios - Interim Ratios 30
Financial Ratios - Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33
EnWave Corp, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Aug 26, 2016: EnWave Announces 2016 Third Quarter Consolidated Interim Financial Results 35
Jul 28, 2016: EnWave Hires Experienced Senior Vice President to Lead Global Pharmaceutical Business Development Strategy 36
May 26, 2016: EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016 37
Feb 26, 2016: EnWave Reports Consolidated Interim Financial Results for the First Quarter Fiscal Year 2016 38
Dec 18, 2015: EnWave Reports 2015 Annual Financial Results 39
Sep 29, 2015: EnWave Subsidiary, Hans Binder Maschinenbau GmbH, Files for Insolvency 40
Sep 04, 2015: EnWave Begins Manufacturing Phase of Agreement Signed with Sutro Biopharma 41
Sep 01, 2015: EnWave Announces New Chief Financial Officer 42
Aug 14, 2015: EnWave Subsidiary, NutraDried, Signs Master Supply and Distribution Agreement with Spire Enterprises 43
Jul 20, 2015: EnWave Further Strengthens Intellectual Property Portfolio, Obtains powderREV, freezeREV and quantaREV Patents, Extends Royalty Stream Timeline 44
Section 6 – Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
EnWave Corp, Key Facts 6
EnWave Corp, Key Employees 7
EnWave Corp, Key Employee Biographies 8
EnWave Corp, Major Products and Services 9
EnWave Corp, History 10
EnWave Corp, Subsidiaries 18
EnWave Corp, Key Competitors 25
EnWave Corp, Ratios based on current share price 26
EnWave Corp, Annual Ratios 27
EnWave Corp (Cont...1), Annual Ratios 28
EnWave Corp, Interim Ratios 30
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 33
EnWave Corp, Recent Deals Summary 34
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 47
Efficiency Ratios 48

List of Figures
EnWave Corp, Performance Chart (2011 - 2015) 29
EnWave Corp, Ratio Charts 31
EnWave Corp, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 32
EnWave Corp, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 33

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838